GT
HAE icon

Glenmede Trust’s Haemonetics HAE Stock Holding History

Glenmede Trust’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.3M Buy
+204,653
New +$13.1M 0.07% 249
2020
Q2 		– Sell
-1,881
Closed -$216K – 2519
2020
Q1 		$216K Hold
1,881
– – ﹤0.01% 1170
2019
Q4 		$216K Buy
1,881
+97
+5% +$11.7K ﹤0.01% 1170
2019
Q3 		$225K Buy
1,784
+13
+0.7% +$1.65K ﹤0.01% 1122
2019
Q2 		$213K Sell
1,771
-205
-10% -$20.2K ﹤0.01% 1141
2019
Q1 		$172K Sell
1,976
-302
-13% -$27.5K ﹤0.01% 1230
2018
Q4 		$227K Buy
+2,278
New +$239K ﹤0.01% 1068
2018
Q3 		– Sell
-1,376
Closed -$122K – 1603
2018
Q2 		$122K Buy
1,376
+1,086
+374% +$91.7K ﹤0.01% 1205
2018
Q1 		$16K Hold
290
– – ﹤0.01% 2040
2017
Q4 		$16K Buy
290
+139
+92% +$7.32K ﹤0.01% 2040
2017
Q3 		$6K Sell
151
-45
-23% -$1.87K ﹤0.01% 2307
2017
Q2 		$7K Hold
196
– – ﹤0.01% 2205
2017
Q1 		$7K Buy
196
+164
+513% +$6.41K ﹤0.01% 2205
2016
Q4 		$1K Buy
+32
New +$1.21K ﹤0.01% 2407
2016
Q3 		– Sell
-140
Closed -$4K – 2622
2016
Q2 		$4K Sell
140
-83
-37% -$2.51K ﹤0.01% 2279
2016
Q1 		$7K Buy
223
+56
+34% +$1.81K ﹤0.01% 2130
2015
Q4 		$4K Hold
167
– – ﹤0.01% 2319
2015
Q3 		$4K Buy
167
+43
+35% +$1.62K ﹤0.01% 2357
2015
Q2 		$4K Buy
124
+24
+24% +$1.01K ﹤0.01% 2282
2015
Q1 		$4K Hold
100
– – ﹤0.01% 2278
2014
Q4 		$3K Hold
100
– – ﹤0.01% 2377
2014
Q3 		$3K Sell
100
-150
-60% -$5.35K ﹤0.01% 2316
2014
Q2 		$8K Buy
250
+100
+67% +$3.34K ﹤0.01% 2086
2014
Q1 		$4K Hold
150
– – ﹤0.01% 2192
2013
Q4 		$6K Hold
150
– – ﹤0.01% 2092
2013
Q3 		$5K Hold
150
– – ﹤0.01% 2045
2013
Q2 		$6K Buy
+150
New +$6.07K ﹤0.01% 1967

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Glenmede Trust's HAE Position: Q2 2026 in Review

Glenmede Trust opened a new position in Haemonetics (HAE) in Q2 2026: 204,653 shares worth $15.3M. The stake represents 0.07% of the portfolio and ranks #249 among its holdings. This is a return to the name: Glenmede Trust previously reported a position in HAE as recently as Q1 2020.

Glenmede Trust first reported a position in HAE in Q2 2013 and has held it in 27 quarters since. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Glenmede Trust held 204,653 shares of Haemonetics worth $15.3M as of Q2 2026.
  • Haemonetics was a new Glenmede Trust position in Q2 2026.
  • Haemonetics made up 0.07% of Glenmede Trust's portfolio in Q2 2026, its #249 holding.
  • Glenmede Trust first reported a position in Haemonetics in Q2 2013 and has held it in 27 quarters since.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Glenmede Trust's 13F filing for Q2 2026, filed 10 Aug 2026.